NCT00185094

A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin

The Effects of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on Insulin Sensitivity in Overweight and Obese Subjects With Hypertension

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (planned)
• Sponsor: Daiichi Sankyo · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

To examine the effect of three different blood pressure medications on the insulin sensitivity in overweight patients with high blood pressure.

Conditions

• Hypertension
• Insulin Resistance
• Metabolic Syndrome

Interventions

Type	Name	Description
DRUG	Olmesartan medoxomil
DRUG	Losartan potassium
DRUG	Atenolol

Timeline

• Start date: 2004-02-01
• Completion: 2005-07-01
• First posted: 2005-09-16
• Last updated: 2005-12-23

Locations

10 sites across 1 country: United States